ESRP1 and neoplasm: found that the expression of ESRP1, an EMT splicing regulator, is negatively correlated with tumor-associated immune cell cytotoxicity in various types of tumors, suggesting a link between the EMT status of tumors and the activity of infiltrating lymphocytes.